Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.

@article{Badar2013ProvisionOG,
  title={Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.},
  author={Athar A Badar and Jennifer Scaife and Andrew T Yan and Simon Daniel Robinson and Azfar Zaman and Ian F Purcell and Javed M. Ahmed and Mohaned Egred and R. J. G. Edwards and Ioakim Spyridopoulos and Bernard D Keavney and Alan J Bagnall},
  journal={The Journal of invasive cardiology},
  year={2013},
  volume={25 8},
  pages={397-401}
}
BACKGROUND Gastrointestinal (GI) bleeding following percutaneous coronary intervention (PCI) is associated with increased mortality. ACCF/AHA/SCAI guidelines recommend prophylaxis to prevent GI bleeding in patients, with the highest GI bleeding risks taking dual-antiplatelet therapy (DAPT). The REPLACE risk score identifies factors predictive of peri-PCI bleeding from vascular access and non-access sites. We determined whether high bleeding risk acute coronary syndrome (ACS) patients taking… CONTINUE READING